Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial.

Yim, Hyung Joon

Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial. [electronic resource] - The American journal of gastroenterology 08 2020 - 1217-1225 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1572-0241

10.14309/ajg.0000000000000605 doi


Adult
Antiviral Agents--administration & dosage
Bone Density
Double-Blind Method
Drug Administration Schedule
Female
Guanine--administration & dosage
Hepatitis B virus
Hepatitis B, Chronic--blood
Humans
Male
Middle Aged
Organophosphonates--administration & dosage
Republic of Korea
Tenofovir--administration & dosage
Treatment Outcome
Viral Load